Auswahl der wissenschaftlichen Literatur zum Thema „Drug screenings“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Drug screenings" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Drug screenings"
O’Neil, Meghan M. „Drug Screenings in Practice“. Federal Sentencing Reporter 36, Nr. 4 (01.04.2024): 212–17. http://dx.doi.org/10.1525/fsr.2024.36.4.212.
Der volle Inhalt der QuelleLiang, Qiying, Peng Ma, Qi Zhang, Youjie Yin, Ping Wang, Saifei Wang, Yao Zhang, Ruolei Han und Hansong Deng. „A gum Arabic assisted sustainable drug delivery system for adult Drosophila“. Biology Open 9, Nr. 6 (02.06.2020): bio052241. http://dx.doi.org/10.1242/bio.052241.
Der volle Inhalt der QuellePopova, Anna A., Claire Depew, Katya Manuella Permana, Alexander Trubitsyn, Ravindra Peravali, Jorge Ángel González Ordiano, Markus Reischl und Pavel A. Levkin. „Evaluation of the Droplet-Microarray Platform for High-Throughput Screening of Suspension Cells“. SLAS TECHNOLOGY: Translating Life Sciences Innovation 22, Nr. 2 (15.11.2016): 163–75. http://dx.doi.org/10.1177/2211068216677204.
Der volle Inhalt der QuelleVacchina, Paola, und Miguel A. Morales. „In VitroScreening Test Using Leishmania Promastigotes Stably Expressing mCherry Protein“. Antimicrobial Agents and Chemotherapy 58, Nr. 3 (06.01.2014): 1825–28. http://dx.doi.org/10.1128/aac.02224-13.
Der volle Inhalt der QuelleHann, Christina. „Random Drug Screenings: Nothing to Lose?“ American Pharmacy 27, Nr. 10 (Oktober 1987): 34–36. http://dx.doi.org/10.1016/s0160-3450(16)33340-2.
Der volle Inhalt der QuelleWilliams, Petal Petersen, Catherine Mathews, Esmé Jordaan, Yukiko Washio, Mishka Terplan und Charles DH Parry. „Validation of simple dichotomous self-report on prenatal alcohol and other drug use in women attending midwife obstetric units in the Cape Metropole, South Africa“. Clinical Ethics 15, Nr. 4 (31.05.2020): 181–86. http://dx.doi.org/10.1177/1477750920928885.
Der volle Inhalt der QuelleNguemeni Tiako, Max Jordan, Abby Dolan, Matthew Abrams, Kehinde Oyekanmi, Zachary Meisel und Shoshana V. Aronowitz. „Thematic Analysis of State Medicaid Buprenorphine Prior Authorization Requirements“. JAMA Network Open 6, Nr. 6 (15.06.2023): e2318487. http://dx.doi.org/10.1001/jamanetworkopen.2023.18487.
Der volle Inhalt der QuelleSalas-Sarduy, Emir, Gabriela T. Niemirowicz, Juan José Cazzulo und Vanina E. Alvarez. „Target-based Screening of the Chagas Box: Setting Up Enzymatic Assays to Discover Specific Inhibitors Across Bioactive Compounds“. Current Medicinal Chemistry 26, Nr. 36 (13.12.2019): 6672–86. http://dx.doi.org/10.2174/0929867326666190705160637.
Der volle Inhalt der QuelleDegliesposti, Gianluca, Corinne Portioli, Marco Daniele Parenti und Giulio Rastelli. „BEAR, a Novel Virtual Screening Methodology for Drug Discovery“. Journal of Biomolecular Screening 16, Nr. 1 (17.11.2010): 129–33. http://dx.doi.org/10.1177/1087057110388276.
Der volle Inhalt der QuelleBintener, Tamara, Maria Pires Pacheco und Thomas Sauter. „Towards the routine use of in silico screenings for drug discovery using metabolic modelling“. Biochemical Society Transactions 48, Nr. 3 (05.05.2020): 955–69. http://dx.doi.org/10.1042/bst20190867.
Der volle Inhalt der QuelleDissertationen zum Thema "Drug screenings"
Myers, Mason Thomas. „Combining Primary Specificity Screenings for Drug Discovery Targeting T-box Antiterminator RNA“. Ohio University Honors Tutorial College / OhioLINK, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=ouhonors1619173211823351.
Der volle Inhalt der QuelleGorgulla, Christoph [Verfasser]. „Free Energy Methods Involving Quantum Physics, Path Integrals, and Virtual Screenings : Development, Implementation and Application in Drug Discovery / Christoph Gorgulla“. Berlin : Freie Universität Berlin, 2018. http://d-nb.info/1159900655/34.
Der volle Inhalt der QuelleMavridis, Lazaros. „High throughput virtual drug screening using spherical harmonic molecular surface representations“. Thesis, Available from the University of Aberdeen Library and Historic Collections Digital Resources, 2009. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?application=DIGITOOL-3&owner=resourcediscovery&custom_att_2=simple_viewer&pid=25936.
Der volle Inhalt der QuelleBaker, Nicola Louise. „Screening for new natural drugs and drug resistance determinants in African trypanosomiasis“. Thesis, London School of Hygiene and Tropical Medicine (University of London), 2013. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.590629.
Der volle Inhalt der QuelleWolbers, Floor. „Apoptosis chip for drug screening“. Enschede : University of Twente [Host], 2007. http://doc.utwente.nl/57881.
Der volle Inhalt der QuelleLarson, Joeanna Lee. „Perinatal Drug Abuse Intervention: Policy Development for Drug Screening“. ScholarWorks, 2016. https://scholarworks.waldenu.edu/dissertations/2555.
Der volle Inhalt der QuelleGuimaraes, A. „Screening molecular interactions for drug discovery“. Thesis, University College London (University of London), 2013. http://discovery.ucl.ac.uk/1389941/.
Der volle Inhalt der QuelleLi, Yifan. „Optimal pool size for pooled drug screening“. Thesis, McGill University, 2011. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=104708.
Der volle Inhalt der QuelleNous addressons le problème de la determination des groupes de substances chimiques pour obtenir des nouveaux traitements. Le but est d'automatiser l'analyse des librairies des larges librairies chimiques et pharmacologiques. L'hypothese de base est qu'il y a un groupe de substances qui ont un effect positif sur une certaine maladie, mais on doit l'identifier par l'analyse d'un très large groupe de substances. Dans ce groupe, il y a aussi des substances qui peuvent masquer l'effet désirable. Nous proposons une formule pour calculer le nombre optimal de substances qu'on devrait tester à la meme fois. La conclusion surprenante est que ce nombre ne depend pas des erreures qu'on fait dans les mesurements. Nous etablissons aussi le nombre de combinaisons qu'on devrait tester pour identifier le groupe desiré. Nouspresentons aussi une approche Bayesienne qu'on peut utiliser quand le nombre des substances bloquant l'effect desiré n'est pas connu.
Pagnotta, Giorgia <1995>. „3D bioprinted organ models for drug screening“. Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2022. http://amsdottorato.unibo.it/10326/1/Pagnotta_Giorgia_tesi.pdf.
Der volle Inhalt der QuellePsaroudakis, G. „Virtual screening in drug design and model evaluation“. Thesis, University of Essex, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.422234.
Der volle Inhalt der QuelleBücher zum Thema "Drug screenings"
Taha, Mutasem Omar. Virtual screening. Croatia: Intech, 2012.
Den vollen Inhalt der Quelle finden1947-, Seethala Ramakrishna, und Fernandes P. B, Hrsg. Handbook of drug screening. New York: Marcel Dekker, 2001.
Den vollen Inhalt der Quelle findenNational Institute on Drug Abuse., Hrsg. Employee drug screening: Detection of drug use by urinalysis. Rockville, Md: U.S. Dept. of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute on Drug Abuse, 1986.
Den vollen Inhalt der Quelle finden1952-, Teicher Beverly A., und Andrews Paul A, Hrsg. Anticancer drug development guide: Preclinical screening, clinical trials, and approval. 2. Aufl. Totowa, N.J: Humana Press, 2004.
Den vollen Inhalt der Quelle findenJörg, Hüser, Hrsg. High-throughput screening in drug discovery. Weinheim: Wiley-VCH, 2006.
Den vollen Inhalt der Quelle findenThompson, Emmanuel B. Drug bioscreening: Drug evaluation techniques in pharmacology. New York: VCH, 1990.
Den vollen Inhalt der Quelle findenHans-Joachim, Böhm, und Schneider Gisbert 1965-, Hrsg. Virtual screening for bioactive molecules. Weinheim: Wiley-VCH, 2000.
Den vollen Inhalt der Quelle findenDrug bioscreening: Fundamentals of drug evaluation techniques in pharmacology. Flushing, N.Y: Graceway Pub. Co., 1985.
Den vollen Inhalt der Quelle findenW, Erhardt P., und International Union of Pure and Applied Chemistry., Hrsg. Drug metabolism: Databases and high-throughput testing during drug design and development. Oxford: Blackwell Science, 1999.
Den vollen Inhalt der Quelle findenG, Welling Peter, Lasagna Louis 1923- und Banakar Umesh V. 1956-, Hrsg. The drug development process. New York: M. Dekker, 1996.
Den vollen Inhalt der Quelle findenBuchteile zum Thema "Drug screenings"
Jung, Matthias, Juliane-Susanne Jung, Jovita Schiller und Insa S. Schroeder. „Disease-Specific Stem Cell Models for Toxicological Screenings and Drug Development“. In Stem Cells in Toxicology and Medicine, 122–44. Chichester, UK: John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781119135449.ch7.
Der volle Inhalt der QuelleBarh, Debmalya, Shoaib Ahmad und Atanu Bhattacharjee. „In Silico and Ultrahigh-Throughput Screenings (uHTS) in Drug Discovery: An Overview“. In Pharmaceutical Biotechnology, 451–90. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 2012. http://dx.doi.org/10.1002/9783527632909.ch18.
Der volle Inhalt der QuelleMohty, Razan, und Arafat Tfayli. „General Oncology Care in Lebanon“. In Cancer in the Arab World, 115–32. Singapore: Springer Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-7945-2_8.
Der volle Inhalt der QuelleCummins, David Jesse. „Pharmaceutical Drug Discovery: Designing the Blockbuster Drug“. In Screening, 69–114. New York, NY: Springer New York, 2006. http://dx.doi.org/10.1007/0-387-28014-6_4.
Der volle Inhalt der QuelleMacolino-Kane, Christine M., John R. Ciallella, Christopher A. Lipinski und Andrew G. Reaume. „Phenotypic Screening“. In Drug Repositioning, 121–45. Boca Raton: CRC Press, [2017] | Series: Frontiers in Neurotherapeutics series: CRC Press, 2017. http://dx.doi.org/10.4324/9781315373669-7.
Der volle Inhalt der QuelleHughes-Oliver, Jacqueline M. „Pooling Experiments for Blood Screening and Drug Discovery“. In Screening, 48–68. New York, NY: Springer New York, 2006. http://dx.doi.org/10.1007/0-387-28014-6_3.
Der volle Inhalt der QuelleDuong, Huynh P., Warunee Dansithong, Daniel R. Scoles und Stefan M. Pulst. „Advanced Gene-Targeting Methods to Generate Cell Line Models that Preserve Native Regulatory Elements for Efficient High-Throughput Drug Screenings“. In 6th International Conference on the Development of Biomedical Engineering in Vietnam (BME6), 643–47. Singapore: Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-4361-1_110.
Der volle Inhalt der QuelleSantos Nascimento, Igor José dos, und Ricardo Olimpio de Moura. „Ligand and Structure-Based Drug Design (LBDD and SBDD): Promising Approaches to Discover New Drugs“. In Applied Computer-Aided Drug Design: Models and Methods, 1–32. BENTHAM SCIENCE PUBLISHERS, 2023. http://dx.doi.org/10.2174/9789815179934123010003.
Der volle Inhalt der Quelle„Drug Repositioning Using Genome-wide Screening and Systems Biology Approaches and Applications“. In Cheminformatics and Bioinformatics at the Interface with Systems Biology, 31–51. Royal Society of Chemistry, 2023. http://dx.doi.org/10.1039/9781839166037-00031.
Der volle Inhalt der Quelle„Screening for Drugs“. In Quick Reference Guide to Pediatric Care, 1246–49. American Academy of Pediatrics, 2005. http://dx.doi.org/10.1542/9781581106220-part01-screening-drug.
Der volle Inhalt der QuelleKonferenzberichte zum Thema "Drug screenings"
Distinto, Simona, und Elias Maccioni. „In Silico Approaches for Drug Discovery Focus on Virtual Screenings“. In Sinteza 2022. Beograd, Serbia: Singidunum University, 2022. http://dx.doi.org/10.15308/sinteza-2022-360-364.
Der volle Inhalt der QuelleBramante, Simona, Vilja Pietiäinen, Lassi Paavolainen, Annukka Pasanen, Netta Mäkinen, Hanna-Riikka Heinonen, Pirjo Ikonen et al. „Abstract 1159: Development of uterine leiomyoma 3D in vitro models for high-throughput drug and chemical compound screenings: Towards personalized medicine“. In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-1159.
Der volle Inhalt der QuelleDereli-Korkut, Zeynep, und Sihong Wang. „Microfluidic Cell Arrays to Mimic 3D Tissue Microenvironment“. In ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80411.
Der volle Inhalt der QuelleMa, Liang, Jeremy Barker, Changchun Zhou, Biaoyang Lin und Wei Li. „A Perfused Two-Chamber System for Anticancer Drug Screening“. In ASME 2010 International Manufacturing Science and Engineering Conference. ASMEDC, 2010. http://dx.doi.org/10.1115/msec2010-34326.
Der volle Inhalt der QuelleGeorge, Subin M., und Hyejin Moon. „Digital Microfluidic Platform for 3-D Tissue Based High Throughput Screening“. In ASME 2011 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2011. http://dx.doi.org/10.1115/sbc2011-53995.
Der volle Inhalt der QuelleFavreau, Peter, Cheri Pasch, Dustin Deming und Melissa Skala. „Autofluorescence metabolic drug screening in colorectal cancer spheroids“. In Optical Molecular Probes, Imaging and Drug Delivery. Washington, D.C.: OSA, 2017. http://dx.doi.org/10.1364/omp.2017.oms2d.4.
Der volle Inhalt der QuelleChen, Ying-Ting, Ren-Guei Wu, Chung-Shi Yang und Fan-Gang Tseng. „Cocktail drug delivery chip for cancer drug screening“. In TRANSDUCERS 2015 - 2015 18th International Solid-State Sensors, Actuators and Microsystems Conference. IEEE, 2015. http://dx.doi.org/10.1109/transducers.2015.7181028.
Der volle Inhalt der QuelleFukunishi, Yoshifumi, Theodore E. Simos und George Maroulis. „Structure-based Drug Screening and Ligand-Based Drug Screening Toward Protein-Compound Network“. In COMPUTATIONAL METHODS IN SCIENCE AND ENGINEERING: Theory and Computation: Old Problems and New Challenges. Lectures Presented at the International Conference on Computational Methods in Science and Engineering 2007 (ICCMSE 2007): VOLUME 1. AIP, 2007. http://dx.doi.org/10.1063/1.2836070.
Der volle Inhalt der QuelleHagan, Daniel M., und Martin T. Hagan. „Virtual drug screening using neural networks“. In 2016 International Joint Conference on Neural Networks (IJCNN). IEEE, 2016. http://dx.doi.org/10.1109/ijcnn.2016.7727252.
Der volle Inhalt der QuelleKannam, Sridhar K., Matthew T. Downton, Natalie Gunn, Sung Cheol Kim, Priscilla R. Rogers, Christine Schieber, Julia S. Baldauf et al. „Nanosensors for next generation drug screening“. In SPIE Micro+Nano Materials, Devices, and Applications, herausgegeben von James Friend und H. Hoe Tan. SPIE, 2013. http://dx.doi.org/10.1117/12.2033737.
Der volle Inhalt der QuelleBerichte der Organisationen zum Thema "Drug screenings"
McNeany, Karen I. USER S GUIDE FOR THE RANDOM DRUG SCREENING SYSTEM. Office of Scientific and Technical Information (OSTI), Dezember 2013. http://dx.doi.org/10.2172/1154773.
Der volle Inhalt der QuelleAger, Arba L., und Jr. Screening and Evaluation of Experimental Antiparasitic Drugs. Fort Belvoir, VA: Defense Technical Information Center, Juni 1991. http://dx.doi.org/10.21236/ada240647.
Der volle Inhalt der QuelleYang, In H. Novel High-Throughput Drug Screening Platform for Chemotherapy-Induced Axonal Neuropathy. Fort Belvoir, VA: Defense Technical Information Center, Mai 2014. http://dx.doi.org/10.21236/ada613177.
Der volle Inhalt der QuelleYang, In H. Novel High-Throughput Drug Screening Platform for Chemotherapy-Induced Axonal Neuropathy. Fort Belvoir, VA: Defense Technical Information Center, Mai 2013. http://dx.doi.org/10.21236/ada581346.
Der volle Inhalt der QuelleJohnson, Corey, Colton James, Sarah Traughber und Charles Walker. Postoperative Nausea and Vomiting Implications in Neostigmine versus Sugammadex. University of Tennessee Health Science Center, Juli 2021. http://dx.doi.org/10.21007/con.dnp.2021.0005.
Der volle Inhalt der QuelleAger Jr, Arba L. The Screening and Evaluation of Experimental Antiparasitic Drugs. Fort Belvoir, VA: Defense Technical Information Center, August 1990. http://dx.doi.org/10.21236/ada238551.
Der volle Inhalt der QuelleBisoffi, Marco. Curcumin Based Drug Screening for Inhibitors of NF kappa B in a Cell Model of Prostate Cancer Progression. Fort Belvoir, VA: Defense Technical Information Center, Februar 2008. http://dx.doi.org/10.21236/ada482629.
Der volle Inhalt der QuelleTurpin, James A. Drug Development and Convervation of Biodiversity in West and Central Africa/in Vitro Antiviral Screening of Plant Extracts and Isolates. Fort Belvoir, VA: Defense Technical Information Center, November 2000. http://dx.doi.org/10.21236/ada383151.
Der volle Inhalt der QuellePeter W. Carr, K.M. Fuller, D.R. Stoll, L.D. Steinkraus, M.S. Pasha und Glenn G. Hardin. Fast Gradient Elution Reversed-Phase HPLC with Diode-Array Detection as a High Throughput Screening Method for Drugs of Abuse. Office of Scientific and Technical Information (OSTI), Dezember 2005. http://dx.doi.org/10.2172/892807.
Der volle Inhalt der QuelleLehotay, Steven J., und Aviv Amirav. Ultra-Fast Methods and Instrumentation for the Analysis of Hazardous Chemicals in the Food Supply. United States Department of Agriculture, Dezember 2012. http://dx.doi.org/10.32747/2012.7699852.bard.
Der volle Inhalt der Quelle